Assessment of Potential Risk of Progressive Multifocal Leukoencephalopathy with Fingolimod Compared with That of Natalizumab (P01.160)
作者
Gordon Francis,Frank Dahlke,Philipp von Rosenstiel,Nikolaos Sfikas
出处
期刊:Neurology [Lippincott Williams & Wilkins] 日期:2013-02-12卷期号:80 (7_supplement)被引量:1
标识
DOI:10.1212/wnl.80.7_supplement.p01.160
摘要
OBJECTIVE: To evaluate potential risk of progressive multifocal leukoencephalopathy (PML) with fingolimod treatment and compare with risk seen with natalizumab in patients with multiple sclerosis (MS).